CDK9-IN-42
CDK9-IN-42 is a potent and selective CDK9 inhibitor with an IC50 value of 3.8 nM. It inhibits cancer cell growth and induces apoptosis by downregulating Myc-1 and c-Myc. CDK9-IN-42 is applicable in cancer research, including studies on breast cancer and lung cancer.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog